Pharmacological treatment of early psychosis: risks and benefits

por Sīle, L.
Publicado 2023

Early intervention in psychosis: An innovation trigger in a challenging environment

por Sile, L., Rancans, E.
Publicado 2021

Patient adherence to out-patient psychiatric care for neurotic and affective disorders (Should I stay, or should I go?)

por Soboļevs, A., Kozlova, K., Tērauds, E., Sīle, L.
Publicado 2022

Practical observations - the COVID-19 influence on latvian early intervention work with first episode psychosis (FEP) patients

por Kokina, N., Sile, L., Butorins, B., Pocopko, A., Lesina, A., Kikuste, S., Sapele, I., Rancans, E.
Publicado 2021

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised...

por Lawrence, David S., Youssouf, Nabila, Molloy, Síle L. F., Alanio, Alexandre, Alufandika, Melanie, Boulware, David R., Boyer-Chammard, Timothée, Chen, Tao, Dromer, Francoise, Hlupeni, Admire, Hope, William, Hosseinipour, Mina C., Kanyama, Cecilia, Lortholary, Oliver, Loyse, Angela, Meya, David B., Mosepele, Mosepele, Muzoora, Conrad, Mwandumba, Henry C., Ndhlovu, Chiratidzo E., Niessen, Louis, Schutz, Charlotte, Stott, Katharine E., Wang, Duolao, Lalloo, David G., Meintjes, Graeme, Jaffar, Shabbar, Harrison, Thomas S., Jarvis, Joseph N.
Publicado 2018